Zobrazeno 1 - 10
of 586
pro vyhledávání: ''
Autor:
Masanori Hayashi, Tetsuro Yamagishi, Chihaya Imai, Hajime Umezu, Takashi Ariizumi, Yudai Murayama, Akira Ogose, Naoki Oike, Hiroyuki Kawashima, Hiroshi Hatano, Naoto Endo
Publikováno v:
Cancer Immunology, Immunotherapy
The characteristics of the tumor immune microenvironment remains unclear in liposarcomas, and here we aimed to determine the prognostic impact of the tumor immune microenvironment across separate liposarcomas subtypes. A total of 70 liposarcoma patie
Autor:
Wen-Ming Chen, Jianyong Li, Hua-Yuan Zhu, Lei Fan, Li Wang, Jin-Hua Liang, Zhen Wang, Dao-Ping Sun, Yu-Jie Wu, Wei Xu
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Purpose To explore the clinical features and immunological mechanisms of Castleman disease (CD) complicated with autoimmune diseases (AID). Methods We explored the prevalence and clinical manifestations of CD complicated with AID by reviewing clinica
Autor:
Valentín Ortiz-Maldonado, Susana Rives, Marta Español-Rego, Anna Alonso-Saladrigues, Mercedes Montoro, Laura Magnano, Eva Giné, Mariona Pascal, Marina Díaz-Beyá, Maria Castella, Albert Català, Anna Faura, Luis Gerardo Rodríguez-Lobato, Aina Oliver-Caldes, Alexandra Martínez-Roca, Montserrat Rovira, E Azucena González-Navarro, Juan Ramón Ortega, Joan Cid, Miquel Lozano, Enric Garcia-Rey, Sara Fernández, Pedro Castro, Iolanda Jordan, Neus Villamor, Marta Aymerich, Montserrat Torrebadell, Àngela Deyà, Carlos Fernández de Larrea, Daniel Benitez-Ribas, Esteve Trias, Sara Varea, Gonzalo Calvo, Jordi Esteve, Alvaro Urbano-Ispizua, Manel Juan, Julio Delgado
Publikováno v:
Journal for Immunotherapy of Cancer
The prognosis of patients with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) remains poor, particularly for those relapsing after allogeneic hema-topoietic cell transplantation (alloHCT). Novel agents such as inotuzumab ozogamicin or b
Autor:
Wenlan Chen, Yadan Wang, Yu Hu, Xiaoping Zhang, Heng Mei, Yaogong Wu, Qiuzhe Wei, Wenjing Li, Miaomiao Zhao
Publikováno v:
Leukemia & Lymphoma
Patients with hematological malignancies with immunodeficiency are at high risk for SARS-CoV-2 infection. We retrospective summarized clinical characteristics of coronavirus disease 2019 (COVID-19) inpatients with hematological malignancies, shared t
Autor:
Shi-Wen Zhang, Chunhua Wang, Rongzhen Luo, Li-Li Liu, Jing-Ping Yun, Xia Yang, Xin-Ke Zhang, Xue Chao, Yan-Lin Wen
Publikováno v:
Cancer Immunology, Immunotherapy
The “macrotrabecular-massive” (MTM) pattern of hepatocellular carcinoma (HCC) has been suggested to represent a distinct HCC subtype and is associated with specific molecular features. Since the immune microenvironment is heterogenous in HCC, it
Autor:
Tímea Szekerczés, Katalin Borka, Gábor Lendvai, Zsuzsa Schaff, Gógl A, András Kiss, Ildikó Illyés, Klára Werling, József Mandl
Publikováno v:
Pathology Oncology Research
Although the role of autophagy has been implicated in several forms of chronic hepatitis, it is still not fully understood. Active autophagy eliminates damaged molecules and organelles (such as mitochondria) by lysosomal degradation. In the present s
Autor:
Hui Zhang, Xiao Yunpeng, Jian Zhang, Hua-Xin Liao, Jun Jiang, Qian-Ting Wang, Li Junqi, You-Wen He, Xiaohui Yuan, Shiyou Li, Zhe Li, Yu-Ying Fan, Sheng-Nan Sun, Ming Zeng, Ru-Jin Han, Bin-Bin Zhao, Ying Nie, Tao Lin
Publikováno v:
Cancer Immunology, Immunotherapy. 69:1375-1387
Tumor-associated antigens (TAAs) have been tested in various clinical trials in cancer treatment but the patterns of specific T cell response to personalized TAA immunization remains to be fully understood. We report antigen-specific T cell responses
Autor:
Hetty E. Carraway, Hassan Awada, Seth J. Corey, Carmelo Gurnari, Bhumika J. Patel, Alan E. Lichtin, Jaroslaw P. Maciejewski, Simona Pagliuca, Valeria Visconte, Misam Zawit, Laila Terkawi, Sunisa Kongkiatkamon, Adam Wahida
Publikováno v:
Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::103efc91d57448f28551fc30d9469222
https://hdl.handle.net/2108/311856
https://hdl.handle.net/2108/311856
Autor:
Mario Cazzola, Alessandro M. Vannucchi, Chiara Paoli, Rossella Manfredini, Paola Guglielmelli, Elisa Rumi, Francesco Mannelli, Annalisa Pacilli, Sara Fiaccabrino, Giada Rotunno, Giada Brogi, Giovanni Barosi, Benedetta Sordi, Francesca Gesullo, Carmela Mannarelli, Ilaria M. Marone
Publikováno v:
Blood. 133:2802-2808
TO THE EDITOR: The discovery of prognostically informative mutations in patients with primary myelofibrosis (PMF)[1][1] prompted the development of mutation-enhanced risk scores.[2][2][⇓][3][⇓][4][⇓][5]-[6][6] Among these mutations, those in AS
Autor:
Marjatta Sinisalo, Helena Hohtari, Satu Mustjoki, Kimmo Porkka, Oscar Brück, Panu E. Kovanen, Olli Kallioniemi, Riku Turkki, Sami Blom, Teijo Pellinen
Publikováno v:
Leukemia
As novel immunological treatments are gaining a foothold in the treatment of acute lymphoblastic leukemia (ALL), it is elemental to examine ALL immunobiology in more detail. We used multiplexed immunohistochemistry (mIHC) to study the immune contextu